News

Nomad Foods Limited (NOMD) Q2 2025 Earnings Call Transcript

1 Mins read

Nomad Foods Limited (NYSE:NOMD) Q2 2025 Earnings Call August 6, 2025 8:30 AM ET

Company Participants

Jason English – Corporate Participant
Ruben Sewnarain Baldew – CFO & Director
Stefan Descheemaeker – CEO & Director

Conference Call Participants

Andrew Lazar – Barclays Bank PLC, Research Division
John Joseph Baumgartner – Mizuho Securities USA LLC, Research Division
Jonathan E. Tanwanteng – CJS Securities, Inc.
Scott Michael Marks – Jefferies LLC, Research Division
Stephen Robert R. Powers – Deutsche Bank AG, Research Division

Operator

Greetings, and welcome to the Nomad Foods Second Quarter 2025 Question and Answer Session. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to your host, Jason English, Head of Investor Relations. Thank you. You may now begin.

Jason English

Good morning, everyone, and thank you for joining us today. I hope everyone has had chance to read our press release and listen to our prerecorded management remarks, both of which are available on our website. In addition, we have posted a transcript of the prerecorded remarks and the accompanying presentation.

At the conclusion of today’s live Q&A session, we’ll also post an audio replay of this call. Please note that during today’s Q&A session, we may make forward-looking statements that are based on our view of the company’s prospects, expectations and intentions at this time. Actual results may differ due to risks and uncertainties, which are discussed in our press release, our filings with the SEC and in our investor presentation, which includes cautionary language. We will also discuss non-IFRS financial measures during the call today. These non-IFRS financial measures should not be considered a replacement for and should be read together with IFRS results. Users can find the IFRS to non-IFRS reconciliations within our earnings release and the appendices at the end of the slide presentation available on

Read the full article here

Related posts
News

Halozyme Therapeutics, Inc. (HALO) Discusses to Acquire ElektrofiConferenceCallTranscript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Halozyme Therapeutics, Inc. (NASDAQ:HALO) Halozyme to Acquire Elektrofi Conference Call October 1, 2025 8:30 AM EDT…
News

Australian Foundation Investment Co (AFOVF) Shareholder/Analyst Call Transcript

1 Mins read
Company Participants Craig DrummondRobert Freeman – MD, CEO & DirectorDavid PeeverMatthew Rowe – Company SecretaryAndrew J. Porter – CFO & Company SecretaryGeoffrey…
News

Unilever: Strong Brands But Fragile Financials – Why I’m Bearish (NYSE:UL)

1 Mins read
This article was written by Follow I am a UK-based equity enthusiast and private investor with a professional background in finance. With…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *